Mutational Genomics for Cancer Pathway Discovery
We propose mutational genomics as an approach for identifying putative cancer pathways. This approach relies on expression profiling tumors that are induced by retroviral insertional mutagenesis. Akin to genetical genomics, this provides the opportunity to search for associations between tumor-initiating events (the viral insertion sites) and the consequent transcription changes, thus revealing putative regulatory interactions. An important advantage is that in mutational genomics the selective pressure exerted by the tumor growth is exploited to yield a relatively small number of loci that are likely to be causal for tumor formation. This is unlike genetical genomics which relies on the natural occurring genetic variation between samples to reveal the effects of a locus on gene expression.
We performed mutational genomics using a set of 97 lymphoma from mice presenting with splenomegaly. This identified several known as well as novel interactions, including many known targets of Notch1 and Gfi1. In addition to direct one-to-one associations, many multilocus networks of association were found. This is indicative of the fact that a cell has many parallel possibilities in which it can reach a state of uncontrolled proliferation. One of the identified networks suggests that Zmiz1 functions upstream of Notch1. Taken together, our results illustrate the potential of mutational genomics as a powerful approach to dissect the regulatory pathways of cancer.
Unable to display preview. Download preview PDF.
- 2.van’t Veer, L.J., Dai, H., van de Vijver, M.J., He, Y.D., Hart, A.A.M., et al.: Gene expression profiling predicts clinical outcome of breast cancer. Nature 415, 530–536 (2002)Google Scholar
- 3.van de Vijver, M.J., He, Y.D., van’t Veer, L.J., Dai, H., Hart, A.A.M., et al.: A gene-expression signature as a predictor of survival in breast cancer. N Engl. J. Med. 347, 1999–2009 (2002)Google Scholar
- 11.Li, J., Burmeister, M.: Genetical genomics: combining genetics with gene expression analysis. Hum. Mol. Genet. 14(spec. 2), R163–R169 (2005)Google Scholar
- 14.Gerrits, A., Li, Y., Tesson, B.M., Bystrykh, L.V., Weersing, E., et al.: Expression quantitative trait loci are highly sensitive to cellular differentiation state. PLoS Genet 5, e1000692 (2009)Google Scholar
- 16.Jonkers, J., Berns, A.: Retroviral insertional mutagenesis as a strategy to identify cancer genes. Biochim. Biophys. Acta 1287, 29–57 (1996)Google Scholar
- 17.de Ridder, J., Gerrits, A., Bot, J., de Haan, G., Reinders, M., et al.: Inferring combinatorial association logic networks in multimodal genome-wide screens. Bioinformatics 26, i149–157 (2010)Google Scholar
- 24.Rouault, J.P., Rimokh, R., Tessa, C., Paranhos, G., Ffrench, M., et al.: Btg1, a member of a new family of antiproliferative genes. EMBO J. 11, 1663–1670 (1992)Google Scholar
- 29.Katoh, M., Katoh, M.: Integrative genomic analyses on hes/hey family: Notch-independent hes1, hes3 transcription in undifferentiated es cells, and notch-dependent hes1, hes5, hey1, hey2, heyl transcription in fetal tissues, adult tissues, or cancer. Int. J. Oncol. 31, 461–466 (2007)Google Scholar
- 31.Dudley, D.D., Wang, H.C., Sun, X.H.: Hes1 potentiates t cell lymphomagenesis by up-regulating a subset of notch target genes. PLoS One 4, e6678 (2009)Google Scholar
- 32.Mattison, J., van der Weyden, L., Hubbard, T., Adams, D.J.: Cancer gene discovery in mouse and man. Biochim. Biophys. Acta 1796, 140–161 (2009)Google Scholar
- 33.de Jong, J., de Ridder, J., van der Weyden, L., Sun, N., van Uitert, M., et al.: Computational identification of insertional mutagenesis targets for cancer gene discovery. Nucleic Acids Res 39, e105 (2011)Google Scholar
- 34.Lin, S.: Rank aggregation methods. Wiley Interdisciplinary Reviews: Computational Statistics (2010)Google Scholar